Alignment Healthcare LLC (ALHC)
Official siteHEALTHCARE • HEALTHCARE PLANS • NASDAQ
Market Cap: $1.54B
Last updated: Nov 17, 2026 at 11:04 AM ET
Alignment Healthcare LLC (ALHC) Earnings: Report Dates and Results
Alignment Healthcare LLC (ALHC) is expected to report earnings on Feb 24, 2027. In the quarter ended Sep 30, 2026, Alignment Healthcare LLC reported EPS of -$0.04, in line with the -$0.04 estimate. It beat the EPS estimate in 6 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
ALHC has an expected report date of Feb 24, 2027.
ALHC Earnings Call
The latest ALHC earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 22 quarters below that had an estimate, ALHC beat 15, missed 6 and matched 1. The widest gap in the table came in the quarter ended Mar 31, 2025, when EPS landed 200.00% above the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.04 | -$0.04 | N/A | 0.00% | In line | -140.0% | 4 | 0 up, 0 down | Oct 29, 2026 | N/A |
| Jun 30, 2026 | $0.17 | $0.13 | N/A | +30.77% | Beat | +21.4% | 4 | 0 up, 0 down | Jul 30, 2026 | $1.34B |
| Mar 31, 2026 | $0.12 | $0.09 | $0.07 - $0.10 | +33.33% | Beat | +200.0% | 4 | 0 up, 0 down | Apr 30, 2026 | $1.24B |
| Dec 31, 2025 | -$0.05 | -$0.15 | N/A | +66.67% | Beat | N/A | 4 | 1 up, 1 down | Feb 26, 2026 | $1.01B |
| Sep 30, 2025 | $0.10 | -$0.01 | -$0.03 - $0.00 | N/A | N/A | N/A | 4 | 0 up, 2 down | Oct 30, 2025 | $993.70M |
| Jun 30, 2025 | $0.14 | $0.01 | -$0.08 - $0.02 | N/A | N/A | N/A | 6 | 0 up, 2 down | Jul 30, 2025 | $1.02B |
| Mar 31, 2025 | $0.04 | -$0.04 | -$0.18 - -$0.03 | +200.00% | Beat | N/A | 5 | 1 up, 0 down | May 1, 2025 | $926.93M |
| Dec 31, 2024 | -$0.06 | -$0.08 | -$0.09 - -$0.08 | +32.14% | Beat | N/A | 5 | 0 up, 0 down | Feb 27, 2025 | $701.24M |
| Sep 30, 2024 | -$0.14 | -$0.08 | N/A | -75.00% | Miss | N/A | 10 | 0 up, 0 down | Oct 29, 2024 | $692.43M |
| Jun 30, 2024 | -$0.03 | -$0.08 | N/A | +62.50% | Beat | N/A | 9 | 0 up, 0 down | Aug 1, 2024 | $681.29M |
| Mar 31, 2024 | -$0.12 | -$0.16 | -$0.26 - -$0.14 | +25.00% | Beat | N/A | 11 | 0 up, 1 down | May 2, 2024 | $628.60M |
| Dec 31, 2023 | -$0.25 | -$0.22 | -$0.25 - -$0.19 | -13.64% | Miss | N/A | 9 | 0 up, 0 down | Feb 27, 2024 | $465.39M |
| Sep 30, 2023 | -$0.18 | -$0.14 | N/A | -28.57% | Miss | N/A | 8 | 0 up, 0 down | Nov 2, 2023 | $456.71M |
| Jun 30, 2023 | -$0.07 | -$0.13 | N/A | +46.15% | Beat | N/A | 7 | 0 up, 0 down | Aug 3, 2023 | $462.38M |
| Mar 31, 2023 | -$0.08 | -$0.11 | N/A | +27.27% | Beat | N/A | 7 | 0 up, 0 down | May 4, 2023 | $439.15M |
| Dec 31, 2022 | -$0.31 | -$0.30 | -$0.31 - -$0.27 | -3.33% | Miss | N/A | 7 | 0 up, 0 down | Feb 28, 2023 | $361.81M |
| Sep 30, 2022 | -$0.21 | -$0.22 | -$0.33 - -$0.20 | +4.55% | Beat | N/A | 7 | 0 up, 0 down | Nov 3, 2022 | $360.35M |
| Jun 30, 2022 | -$0.06 | -$0.16 | N/A | +62.50% | Beat | N/A | 7 | 0 up, 0 down | Aug 4, 2022 | $366.47M |
| Mar 31, 2022 | -$0.07 | -$0.21 | -$0.31 - -$0.14 | +66.67% | Beat | N/A | 8 | 0 up, 0 down | May 5, 2022 | $345.53M |
| Dec 31, 2021 | -$0.27 | -$0.30 | -$0.38 - -$0.19 | +10.00% | Beat | N/A | 8 | N/A | Mar 3, 2022 | $298.27M |
| Sep 30, 2021 | -$0.25 | -$0.14 | -$0.27 - -$0.13 | -78.57% | Miss | N/A | 6 | N/A | Nov 4, 2021 | $293.47M |
| Jun 30, 2021 | -$0.07 | -$0.11 | -$0.12 - -$0.10 | +36.36% | Beat | -198.3% | 4 | N/A | Aug 9, 2021 | $308.95M |
| Mar 31, 2021 | -$0.37 | -$0.19 | -$0.23 - -$0.17 | -94.74% | Miss | -777.7% | 5 | N/A | May 17, 2021 | $267.08M |
| Dec 31, 2020 | -$0.19 | -$0.19 | N/A | +1.79% | Beat | N/A | N/A | N/A | Mar 29, 2021 | $487.90M |
| Jun 30, 2020 | $0.07 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 30, 2020 | $244.31M |
| Mar 31, 2020 | $0.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 29, 2020 | $224.63M |
| Dec 31, 2019 | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2020 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $0.23, a profit after a loss of $0.35 per share the year before. It was -$0.07 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $0.23 | N/A |
| Dec 31, 2024 | -$0.35 | N/A |
| Dec 31, 2023 | -$0.58 | N/A |
| Dec 31, 2022 | -$0.65 | N/A |
| Dec 31, 2021 | -$0.96 | N/A |
| Dec 31, 2020 | -$0.06 | N/A |
| Dec 31, 2019 | -$0.07 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,700 words across 13 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 8,732 | 13 | |
| 2026Q2 | Jun 30, 2026 | 6,010 | 16 | |
| 2026Q1 | Mar 31, 2026 | 7,225 | 15 | |
| 2025Q4 | Dec 31, 2025 | 7,684 | 14 | |
| 2025Q3 | Sep 30, 2025 | 6,446 | 13 | |
| 2025Q2 | Jun 30, 2025 | 6,147 | 13 | |
| 2025Q1 | Mar 31, 2025 | 7,680 | 13 | |
| 2024Q4 | Dec 31, 2024 | 6,202 | 9 |
2026Q3 Earnings Call
Opening remarks
John Kao Chairman and CEO Good afternoon, and thank you for joining us on our third quarter earnings conference call. For the third quarter of 2026, health plan membership of 301,200 represented growth of 31% year over year and drove overall revenue of approximately $1.4 billion, a 37% increase year over year. Adjusted gross profit of $142 million represented an adjusted MBR of 89.5%, a 240-basis-point increase year over year. Meanwhile, adjusted SG&A of $120 million represented an SG&A ratio of 8.9%, which improved by 70 basis points year over year. Taken together, adjusted EBITDA was $22 million, within the range of our guidance. I want to spend a few minutes on the headwinds that emerged this quarter and the actions we have taken in response. As part of our broader scaling initiatives, we began a comprehensive claims system migration last year designed to improve our payment speed, auto-adjudication rates, and payment integrity capabilities. During this transitional period, we experienced greater volatility in claims processing. As this volatility normalized, we identified a notable increase in aggressive provider appeals and disputes in our paid claims data, which resulted in higher cost trends. Separately, during the quarter, we saw pockets of higher costs in areas such as catastrophic cases and skilled nursing, which also pressured medical expenses. To address the headwinds we experienced, we acted swiftly over the past several months to build out a more robust payment integrity function, including industry-standard prepaid claims edits and more rigorous post-pay review. Additionally, we have moved quickly to manage and deploy our clinical resources more effectively and are making targeted investments to ensure clinical best practices and operating rigor are applied systematically across our markets to reduce the variability in member outcomes. We are confident that the actions we are taking to scale our clinical programs will enable us to achieve the level of clinical effectiveness that we are accustomed to. We are pleased with the progress we have made across our multiple initiatives and saw institutional acute cost trends stabilize as we closed out September and entered October. Furthermore, we've experienced positive momentum across other cost categories. Despite our progress, we are taking a prudent approach to the increased trend seen in Q3 and assume that higher costs in the third quarter will continue to weigh on our results for the remainder of the year. Given this position, we lowered our annual guidance to no less than $575 million of adjusted gross profit and $100 million of adjusted EBITDA. I want to emphasize that the guidance we have provided today is guidance that we are confident in delivering.
Frequently Asked Questions About ALHC
When is Alignment Healthcare LLC's next earnings date?
Alignment Healthcare LLC's next earnings report is expected for Feb 24, 2027.
Did ALHC beat earnings estimates last quarter?
Alignment Healthcare LLC reported EPS of -$0.04 for the quarter ended Sep 30, 2026, in line with the -$0.04 estimate.
What EPS do analysts expect from ALHC next quarter?
The consensus EPS estimate for Alignment Healthcare LLC for the quarter ending Dec 31, 2026 is -$0.20 from 17 analysts, with estimates from -$0.29 to -$0.01.
How often does ALHC beat earnings estimates?
Alignment Healthcare LLC beat the EPS estimate in 6 of the 8 most recent quarters that had an estimate, with an average surprise of +43.80%.
ALHC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors